Oasys and occupational asthma banner logo
Log In / Register Password reminder
  Oasys Courses Forums References Referral
Centres		 Causes Shield Case
Histories		 Links
 Home > References > Search Results

Search Results

You searched for the following terms: "". Oasys removes some common words (such as is, at, and etc), and restricts to a maximum of 5 words, so this list may not be the same as the one you entered.

Showing Page 8 of 279 Page: 3 4 5 6 7 8 9 10 11 12 13
Download these 5571 result(s) in MedlineFormat

Abstract Available for Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts Lytras T, Beckmeyer-Borowko A, Kogevinas M, Kromhout H, Carsin A, Antó JM, Bentouhami H, Weyler J, Heinrich J, Nowak D, Urrutia I, Martínez-Moratalla J, Gullón JA, Vega AP, Semjen CR, Pin I, Demoly P, Leynaert B, Villani S, Gislason T, Svanes Ø, Holm M, Forsberg B, Norbäck D, Mehta AJ, Keidel D, Vernez D, Benke G, Jõgi R, Torén K, Sigsgaard T, Schlünssen V, Olivieri M, Blanc PD, Watkins J, Bono R, Squillacioti G, Buist AS, Vermeulen R, Jarvis D, Probst-Hensch N, Zock J, Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts, Ann Am Thorac Soc, 2020;202002-113:202002-113OC,https://doi.org/10.1513/AnnalsATS.202002-113OC
Josep Antó, Barcelona, Catalonia, Spain, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Dennis Nowak, Institute fur Arbeits, Munich, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Torben Sigsgaard, University of Aarhus, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Kjell Toren, Sahlgrenska University Hospital. Goteborg, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Paul Blanc, University of California San Francisco, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Jan-Paul Zock, Municipal Institute of Medical Research, Barcelona, Spain, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Isabel Urrutia, Hospital de Galdakao, Bizkaia, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Vivi Schlunssen, Aarhus, an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts' Dan Norback, , an author of 'Cumulative Occupational Exposures and Lung Function Decline in Two Large General Population Cohorts'

Abstract Available for Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis Adegunsoye A, Morisset J, Newton CA, Oldham JM, Vittinghoff E, Linderholm AL, Strek ME, Noth I, Garcia CK, Wolters PJ, Ley B, Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis, Eur Respir J, 2020;:,10.1183/13993003.02872-2020

Abstract Available for Vaping-Related Acute Parenchymal Lung Injury A Systematic Review Jonas AM, Raj R, Vaping-Related Acute Parenchymal Lung Injury A Systematic Review, Chest, 2020;158:1555-1565,10.1016/j.chest.2020.03.085

Abstract Available for Updated review of reported cases of reactive airways dysfunction syndrome Walters GI, Huntley CC, Updated review of reported cases of reactive airways dysfunction syndrome, Occup Med, 2020;70:490-495,https://doi.org/10.1093/occmed/kqaa133
Gareth Walters, Heartlands, an author of 'Updated review of reported cases of reactive airways dysfunction syndrome' Chris Huntley, University Hospitals Birmingham, an author of 'Updated review of reported cases of reactive airways dysfunction syndrome'

Abstract Available for Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline Raghu G, Remy-Jardin M, Ryerson CJ, Myers JL, Kreuter M, Vasakova M, Bargagli E, Chung JH, Collins BF, Bendstrup E, Chami HA, Chua AT, Corte TJ, Dalphin J, Danoff SK, Diaz-Mendoza J, Duggal A, Egashira R, Ewing T, Gulati M, Inoue Y, Jenkins AR, Johannson KA, Johkoh T, Tamae-Kakazu M, Kitaichi M, Knight SL, Koschel D, Lederer DJ, Mageto Y, Maier LA, Matiz C, Morell F, Nicholson AG, Patolia S, Pereira CA, Renzoni EA, Salisbury ML, Selman M, Walsh SLF, Wuyts WA, and Wilson KC, Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline, Am J Respir Crit Care Med, 2020;202:e36-e69,https://doi.org/10.1164/rccm.202005-2032ST
Ferran Morell, Vall d'Hebron Hospital, Barcelona, an author of 'Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline'

Abstract Available for Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner R-G, Schlenker-Herceg R, Kolb M, Abe S, Aburto M, Acosta O, Andrews C, Antin-Ozerkis D, Arce G, Arias M, Avdeev S, Barczyk A, Bascom R, Bazdyrev E, Beirne P, Belloli E, Bergna MA, Bergot E, Bhatt N, Blaas S, Bondue B, Bonella F, Britt E, Buch K, Burk J, Cai H, Cantin A, Castillo Villegas DM, Cazaux A, Cerri S, Chaaban S, Chaudhuri N, Cottin V, Crestani B, Criner G, Dahlqvist C, Danoff S, Dematte DAmico J, Dilling D, Elias P, Ettinger N, Falk J, Fernández Pérez ER, Gamez-Dubuis A, Giessel G, Gifford A, Glassberg M, Glazer C, Golden J, Gómez Carrera L, Guiot J, Hallowell R, Hayashi H, Hetzel J, Hirani N, Homik L, Hope-Gill B, Hotchkin D, Ichikado K, Ilkovich M, Inoue Y, Izumi S, Jassem E, Jones L, Jouneau S, Kaner R, Kang J, Kawamura T, Kessler R, , Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial, Lancet Respiratory Medicine, 2020;8:453-460,https://doi.org/10.1016/S2213-2600(20)30036-9

Abstract Available for Cleaning products and respiratory health outcomes in occupational cleaners: a systematic review and meta-analysis Archangelidi O, Sathiyajit S, Consonni D, Jarvis D, Matteis SD, Cleaning products and respiratory health outcomes in occupational cleaners: a systematic review and meta-analysis, Occup Environ Med, 2020;:,http://dx.doi.org/10.1136/oemed-2020-106776

Abstract Available for A Potential Health Risk to Occupational User from Exposure to Biocidal Active Chemicals Kim J, Hwang M, Kim Y, A Potential Health Risk to Occupational User from Exposure to Biocidal Active Chemicals, Int J Environ Res Public Health, 2020;17:23,https://doi.org/10.3390/ijerph17238770

Full Text Available for E-cigarettes, vaping-related pulmonary illnesses, and asthma: A perspective from inhalation toxicologists Clapp PW, Peden DB, Jaspers I, E-cigarettes, vaping-related pulmonary illnesses, and asthma: A perspective from inhalation toxicologists, J Allergy Clin Immunol, 2020;145:97-99,https://doi.org/10.1016/j.jaci.2019.11.001

Abstract Available for Bronchial response to high and low molecular weight occupational inhalant allergens. Lipinska-Ojrzanowska A, Nowakowska-Swirta E, Wiszniewska M, Walusiak-Skorupa J, Bronchial response to high and low molecular weight occupational inhalant allergens., Allergy Asthma Immunol Res. 202, 2020;12:164-170,

Abstract Available for Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge Evans ME, Twentyman E, Click ES, Alyson B, Goodman DN, Kiernan E, Hocevar SA, Mikosz CA, Danielson M, Anderson KN, Ellington S, Lozier MJ, Pollack LA, Rose DA, Krishnasamy V, Jones CM, Briss P, King BA, Wiltz, JL, Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge, MMWR CDC Surveill Summ, 2020;68:1189-1194,doi:10.15585/mmwr.mm685152e2

Abstract Available for Are Electronic Cigarette Users at Risk for Lipid-Mediated Lung Injury? Eissenberg T, Wasim Maziak W, Are Electronic Cigarette Users at Risk for Lipid-Mediated Lung Injury?, Am J Respir Crit Care Med, 2020;10.1164/rc:10.1164/,10.1164/rccm.201910-2082LE

Full Text Available for Vaping-induced diffuse alveolar hemorrhage Edmonds PJ, Copeland C, Conger A, Richmond BW, Vaping-induced diffuse alveolar hemorrhage, Respiratory Medicine Case Reports, 2020;29:100996,10.1016/j.rmcr.2020.100996

Full Text Available for Welding fumes, a risk factor for lung diseases. Riccelli MG, Goldoni M, Poli D, Mozzoni P, Cavallo D, & Corradi M, Welding fumes, a risk factor for lung diseases., nternational journal of environmental research and public health, 2020;17:2552,doi:10.3390/ijerph17072552

Abstract Available for IgE-mediated chlorhexidine allergy—Cross-reactivity with other biguanide disinfectants. Mueller-Wirth N, Buenter A, Jörg L, Ebo DG, Glatz M, Fernando SL, Spoerl D, Helbling A, Hausmann O, Gupta N, Pichler WJ, IgE-mediated chlorhexidine allergy—Cross-reactivity with other biguanide disinfectants., Allergy, 2020;75:3237-3247,https://doi.org/10.1111/all.14497
Neeraj Gupta, Maulana Azad Medical College, Delhi, an author of 'IgE-mediated chlorhexidine allergy—Cross-reactivity with other biguanide disinfectants.'

Abstract Available for Aerosol Generation during Spirometry Helgeson SA, Lim KG, Lee AS, Niven AS, Patel NM, Aerosol Generation during Spirometry, Annals of the American Thoracic Society, 2020;17:1637-1639,https://doi.org/10.1513/AnnalsATS.202005-569RL

Abstract Available for Laboratory animal allergy : a changing world Canizales J, Laboratory animal allergy : a changing world, EThOS, 2020;0000 0005:,https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.835418
Jennifer Canizales, Royal Brompton Hospital, an author of 'Laboratory animal allergy : a changing world'

Abstract Available for Exploring the Utility of Noninvasive Type 2 Inflammatory Markers for Prediction of Severe Asthma Exacerbations in Children and Adolescents Shah SP, Grunwell J, Shih J, Stephenson S, Fitzpatrick AM, Exploring the Utility of Noninvasive Type 2 Inflammatory Markers for Prediction of Severe Asthma Exacerbations in Children and Adolescents, J Allergy Clin Immunol Pract, 2019;78:2624-2633,10.1016/j.jaip.2019.04.043

Full Text Available for Comparison of bench test results measuring the accuracy of peak flow meters VanZeller C, Williams A, Pollock I, Comparison of bench test results measuring the accuracy of peak flow meters, BMC Pulmonary Medicine, 2019;19:74,https://doi.org/10.1186/s12890-019-0837-3

Abstract Available for British guideline on the management of asthma Scottish Intercollegiate Guidelines Network British Thoracic Society, British guideline on the management of asthma, Scottish Intercollegiate Guidelines Network, 2019;158:,https://www.sign.ac.uk/our-guidelines/british-guideline-on-the-management-of-asthma/

Showing Page 8 of 279 Page: 3 4 5 6 7 8 9 10 11 12 13

Oasys and occupational asthma smoke logo

Back To Top
Oasys Home

Download Oasys (free) - Using Oasys - Error on page? - Contact Oasys - Oasys Privacy Statement